Fiera Capital (Canada)
ITCI

Fiera Capital (Canada)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Fiera Capital (Canada)’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-18,320
Closed -$298K – 699
2017
Q1 		$298K Hold
18,320
– – ﹤0.01% 572
2016
Q4 		$276K Hold
18,320
– – ﹤0.01% 700
2016
Q3 		$279K Hold
18,320
– – ﹤0.01% 660
2016
Q2 		$711K Hold
18,320
– – ﹤0.01% 605
2016
Q1 		$509K Hold
18,320
– – ﹤0.01% 477
2015
Q4 		$985K Hold
18,320
– – 0.01% 428
2015
Q3 		$734K Hold
18,320
– – 0.01% 402
2015
Q2 		$585 Buy
+18,320
New +$465K ﹤0.01% 429

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return